Single-extracellular vesicle (EV) analyses validate the use of L1 Cell Adhesion Molecule (L1CAM) as a reliable biomarker of neuron-derived EVs.
Level 5 - mechanism / opinion, no new human data
Laboratory methodology and single-vesicle bench study analyzing human blood samples.
PubMed 38868956 · doi:10.1002/jev2.12459
What was done
Multiple single-extracellular vesicle (EV) analytical techniques were applied to human blood samples to assess whether L1 Cell Adhesion Molecule (L1CAM) is specific to neuron-derived EVs (NDEVs). The authors evaluated the co-expression of L1CAM ectodomain epitopes with neuronal markers (β-III-tubulin, GAP43, and VAMP2) on individual EVs and tested whether soluble plasma L1CAM non-specifically binds to single EVs.
What was found
L1CAM ectodomain epitopes co-expressed on single EVs with β-III-tubulin, GAP43, and VAMP2, increasing proportionally with L1CAM-positive EV enrichment. Among L1CAM-positive EVs, 30% to 63% carried the neuronal proteins VAMP2 and β-III-tubulin, compared to only 0.8% to 3.9% of L1CAM-negative EVs. Soluble fluid-phase L1CAM in plasma did not bind to single EVs.
Why it matters
These findings address ongoing methodological debates regarding the specificity of L1CAM immuno-isolation, supporting its continued use as a surface marker to capture circulating neuron-derived EVs for CNS biomarker discovery.
Limits
The abstract does not report the number of human blood donors, donor clinical characteristics, or potential cross-reactivity across different CNS versus peripheral cell types beyond the tested markers. Functional biomarker performance in specific disease cohorts was not assessed.
Cited by
- supports Neural-derived exosomes represent approximately 10% of total circulating exosomes in blood analysis.